| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |